Shulamit Ron-bigger

CHIEF OPERATING OFFICER · AKTIS ONCOLOGY, INC. · CIK 0002049407

FILING MIX · LIFETIME20%/80%

BUYS

SELLS

TOTAL VALUE

$1.57M

COMPANIES

ACTIVE SINCE

Jul 2026

HOLDINGS NOW

AVG SELL PX

$27.75

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Shulamit Ron-bigger. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

AKTS · 0 shares · as of Jul 8, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 1 buys / 4 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
AKTS AKTIS ONCOLOGY, INC.	SALE Chief Operating Officer	4,200	$28.75	$120.7K	0	Jul 8, 2026	Jul 10, 2026 ↗	View →
AKTS AKTIS ONCOLOGY, INC.	SALE Chief Operating Officer	30,000	$27.94	$838.1K	4,200	Jul 8, 2026	Jul 10, 2026 ↗	View →
AKTS AKTIS ONCOLOGY, INC.	SALE Chief Operating Officer	50,000	—	—	217,888	Jul 8, 2026	Jul 10, 2026 ↗	View →
AKTS AKTIS ONCOLOGY, INC.	SALE Chief Operating Officer	15,800	$27.13	$428.7K	34,200	Jul 8, 2026	Jul 10, 2026 ↗	View →
AKTS AKTIS ONCOLOGY, INC.	PURCHASE Chief Operating Officer	50,000	$3.66	$183.0K	50,000	Jul 8, 2026	Jul 10, 2026 ↗	View →

Other insiders · AKTS

Loading peer insiders…

About this filer

CIK 0002049407

ROLE

Chief Operating Officer

PRIMARY

AKTS

COMPANIES

ACTIVE SINCE

Jul 2026

MARKETPEEL · /INSIDER/0002049407DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.